SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?

To: tom pope who wrote (10064)12/19/2008 10:40:41 AM
From: steve kammerer  Read Replies (1) | Respond to of 10345
 
Anyone want to hazard a guess as to what the corresponding ELN price would be? Where do we stand with Alzheimer drug helping only a small population and oral MS drugs coming.
Thanks for any efforts.



To: tom pope who wrote (10064)12/19/2008 12:53:29 PM
From: tuck  Read Replies (2) | Respond to of 10345
 
If this is the female whose case was reported in late October of this year . . . newsflash 45 minutes ago that she passed away earlier this week. Biogen/Elan had held off reporting the death until now out of respect for her family.

Tuck


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News